NDC 14789-201
Colistimethate Sodium
Colistimethate Sodium
Colistimethate Sodium is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Nexus Pharmaceuticals Inc. The primary component is Colistimethate Sodium.
| Product ID | 14789-201_6f7c37e8-0a2b-4036-a037-083fd40cfc50 |
| NDC | 14789-201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Colistimethate Sodium |
| Generic Name | Colistimethate Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2021-12-06 |
| Marketing Category | ANDA / |
| Application Number | ANDA065177 |
| Labeler Name | Nexus Pharmaceuticals Inc |
| Substance Name | COLISTIMETHATE SODIUM |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |